Mission BioCapital (MBC), in partnership with sponsors Eli Lilly and Company (Lilly), Ono Venture Investment (OVI), Alloy Therapeutics, and our newest sponsor, HitGen, announced today that ...

Mark brings 30 years of experience in R&D spanning discovery to late-stage clinical development London, 7 April 2025 - LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech and world ...